pmc-enju-pas Home  

PMC:3312845 / 26911-28469 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T10563 0-5 NN denotes MIP-2
T10564 6-8 VB denotes is
T10565 9-10 DT denotes a
T10566 11-19 JJ denotes powerful
T10567 20-29 NN denotes chemokine
T10568 30-34 WDT denotes that
T10569 35-46 VB denotes contributes
T10570 47-49 TO denotes to
T10571 50-61 NN denotes recruitment
T10572 62-64 IN denotes of
T10573 65-76 NN denotes neutrophils
T10574 77-78 -LRB- denotes [
T10575 78-80 CD denotes 27
T10576 80-81 -RRB- denotes ]
T10577 83-88 NN denotes MIP-2
T10578 89-91 VB denotes is
T10579 92-104 JJ denotes undetectable
T10580 105-107 CC denotes or
T10581 108-115 JJ denotes present
T10582 116-118 IN denotes at
T10583 119-122 JJ denotes low
T10584 123-129 NN denotes levels
T10585 130-135 IN denotes under
T10586 136-149 JJ denotes physiological
T10587 150-160 NN denotes conditions
T10588 160-161 -COMMA- denotes ,
T10589 162-165 CC denotes and
T10590 166-171 VB denotes shows
T10591 172-181 JJ denotes transient
T10592 182-191 NN denotes increases
T10593 192-197 IN denotes under
T10594 198-210 JJ denotes pathological
T10595 211-221 NN denotes conditions
T10596 222-225 IN denotes via
T10597 226-231 NN denotes TNF-α
T10598 232-238 CC denotes and/or
T10599 239-253 NN denotes interleukin-1β
T10600 254-255 -LRB- denotes (
T10601 255-260 NN denotes IL-1β
T10602 260-261 -RRB- denotes )
T10603 261-271 JJ denotes -dependent
T10604 272-282 NN denotes mechanisms
T10605 283-284 -LRB- denotes [
T10606 284-286 CD denotes 14
T10607 286-287 -RRB- denotes ]
T10608 289-293 RB denotes Thus
T10609 293-294 -COMMA- denotes ,
T10610 295-297 PRP denotes it
T10611 298-303 MD denotes would
T10612 304-306 VB denotes be
T10613 307-316 JJ denotes plausible
T10614 317-321 IN denotes that
T10615 322-336 JJ denotes TNF-α-mediated
T10616 337-342 NN denotes MIP-2
T10617 343-353 NN denotes expression
T10618 354-357 MD denotes may
T10619 358-365 VB denotes provoke
T10620 366-376 JJ denotes SE-induced
T10621 377-387 NN denotes neutrophil
T10622 388-401 NN denotes infiltrations
T10623 403-405 TO denotes To
T10624 406-413 VB denotes confirm
T10625 414-418 DT denotes this
T10626 419-429 NN denotes hypothesis
T10627 429-430 -COMMA- denotes ,
T10628 431-433 PRP denotes we
T10629 434-446 VB denotes investigated
T10630 447-452 NN denotes MIP-2
T10631 453-463 NN denotes expression
T10632 464-466 IN denotes in
T10633 467-470 DT denotes the
T10634 471-473 NN denotes PC
T10635 475-485 JJ denotes Consistent
T10636 486-490 IN denotes with
T10637 491-494 PRP-DOLLAR- denotes our
T10638 495-503 JJ denotes previous
T10639 504-509 NN denotes study
T10640 510-511 -LRB- denotes [
T10641 511-513 CD denotes 20
T10642 513-514 -RRB- denotes ]
T10643 514-515 -COMMA- denotes ,
T10644 516-520 DT denotes some
T10645 521-535 JJ denotes MIP-2-positive
T10646 536-546 NN denotes astrocytes
T10647 547-551 VB denotes were
T10648 552-560 VB denotes observed
T10649 561-563 IN denotes in
T10650 564-567 DT denotes the
T10651 568-572 NN denotes core
T10652 573-576 CC denotes and
T10653 577-586 NN denotes periphery
T10654 587-589 IN denotes of
T10655 590-593 DT denotes the
T10656 594-603 JJ denotes vasogenic
T10657 604-609 NN denotes edema
T10658 610-617 NN denotes lesions
T10659 617-618 -COMMA- denotes ,
T10660 619-622 CC denotes but
T10661 623-626 RB denotes not
T10662 627-629 IN denotes in
T10663 630-633 DT denotes the
T10664 634-647 JJ denotes non-vasogenic
T10665 648-653 NN denotes edema
T10666 654-660 NN denotes region
T10667 661-662 -LRB- denotes (
T10668 662-668 NN denotes Figure
T10669 669-671 NN denotes 6B
T10670 672-675 CC denotes and
T10671 676-678 NN denotes 6C
T10672 678-679 -RRB- denotes )
T10673 681-689 IN denotes Although
T10674 690-693 DT denotes the
T10675 694-700 NN denotes number
T10676 701-703 IN denotes of
T10677 704-709 NN denotes MIP-2
T10678 710-718 JJ denotes positive
T10679 719-724 NN denotes cells
T10680 725-728 IN denotes per
T10681 729-733 NN denotes unit
T10682 734-738 NN denotes area
T10683 739-741 IN denotes in
T10684 742-745 DT denotes the
T10685 746-748 NN denotes PC
T10686 749-755 NN denotes region
T10687 756-758 IN denotes of
T10688 759-775 JJ denotes sTNFp55R-infused
T10689 776-783 NN denotes animals
T10690 784-787 VB denotes was
T10691 788-801 RB denotes significantly
T10692 802-807 JJ denotes lower
T10693 808-812 IN denotes than
T10694 813-817 DT denotes that
T10695 818-820 IN denotes of
T10696 821-824 DT denotes the
T10697 825-839 JJ denotes saline-infused
T10698 840-845 NN denotes group
T10699 846-849 JJ denotes due
T10700 850-852 TO denotes to
T10701 853-862 NN denotes reduction
T10702 863-865 IN denotes of
T10703 866-869 DT denotes the
T10704 870-874 NN denotes area
T10705 875-877 IN denotes of
T10706 878-887 JJ denotes vasogenic
T10707 888-893 NN denotes edema
T10708 893-894 -COMMA- denotes ,
T10709 895-900 EX denotes there
T10710 901-904 VB denotes was
T10711 905-907 DT denotes no
T10712 908-918 NN denotes difference
T10713 919-921 IN denotes in
T10714 922-925 DT denotes the
T10715 926-932 NN denotes number
T10716 933-935 IN denotes of
T10717 936-941 NN denotes MIP-2
T10718 942-950 JJ denotes positive
T10719 951-956 NN denotes cells
T10720 957-960 IN denotes per
T10721 961-965 NN denotes unit
T10722 966-970 NN denotes area
T10723 971-973 IN denotes of
T10724 974-983 JJ denotes vasogenic
T10725 984-989 NN denotes edema
T10726 990-997 IN denotes between
T10727 998-1014 JJ denotes sTNFp55R-infused
T10728 1015-1022 NN denotes animals
T10729 1023-1026 CC denotes and
T10730 1027-1041 JJ denotes saline-infused
T10731 1042-1049 NN denotes animals
T10732 1050-1051 -LRB- denotes (
T10733 1051-1057 NN denotes Figure
T10734 1058-1060 NN denotes 6F
T10735 1060-1061 -RRB- denotes )
T10736 1063-1074 RB denotes Furthermore
T10737 1074-1075 -COMMA- denotes ,
T10738 1076-1079 DT denotes the
T10739 1080-1086 NN denotes number
T10740 1087-1089 IN denotes of
T10741 1090-1104 JJ denotes MIP-2-positive
T10742 1105-1110 NN denotes cells
T10743 1111-1117 VB denotes showed
T10744 1118-1119 DT denotes a
T10745 1120-1126 JJ denotes direct
T10746 1127-1137 NN denotes proportion
T10747 1138-1140 TO denotes to
T10748 1141-1144 DT denotes the
T10749 1145-1149 NN denotes unit
T10750 1150-1154 NN denotes area
T10751 1155-1157 IN denotes of
T10752 1158-1167 JJ denotes vasogenic
T10753 1168-1173 NN denotes edema
T10754 1174-1178 IN denotes with
T10755 1179-1180 DT denotes a
T10756 1181-1187 JJ denotes linear
T10757 1188-1199 NN denotes coefficient
T10758 1200-1202 IN denotes of
T10759 1203-1214 NN denotes correlation
T10760 1215-1217 IN denotes of
T10761 1218-1223 CD denotes 0.682
T10762 1224-1225 -LRB- denotes (
T10763 1225-1226 NN denotes p
T10764 1227-1228 SYM denotes <
T10765 1229-1233 CD denotes 0.05
T10766 1233-1234 -COMMA- denotes ,
T10767 1235-1241 NNP denotes Figure
T10768 1242-1244 NN denotes 6G
T10769 1244-1245 -RRB- denotes )
T10770 1247-1256 RB denotes Therefore
T10771 1256-1257 -COMMA- denotes ,
T10772 1258-1266 RB denotes together
T10773 1267-1271 IN denotes with
T10774 1272-1281 NN denotes reduction
T10775 1282-1284 IN denotes in
T10776 1285-1295 NN denotes neutrophil
T10777 1296-1308 NN denotes infiltration
T10778 1309-1311 IN denotes in
T10779 1312-1315 DT denotes the
T10780 1316-1318 NN denotes PC
T10781 1319-1325 NN denotes region
T10782 1326-1328 IN denotes of
T10783 1329-1345 JJ denotes sTNFp55R-infused
T10784 1346-1353 NN denotes animals
T10785 1353-1354 -COMMA- denotes ,
T10786 1355-1358 PRP-DOLLAR- denotes our
T10787 1359-1367 NN denotes findings
T10788 1368-1375 VB denotes provide
T10789 1376-1384 NN denotes evidence
T10790 1385-1389 IN denotes that
T10791 1390-1395 NN denotes TNF-α
T10792 1396-1399 MD denotes may
T10793 1400-1408 VB denotes regulate
T10794 1409-1419 JJ denotes SE-induced
T10795 1420-1430 NN denotes neutrophil
T10796 1431-1443 NN denotes infiltration
T10797 1444-1446 IN denotes at
T10798 1447-1452 JJ denotes least
T10799 1453-1455 IN denotes in
T10800 1456-1459 DT denotes the
T10801 1460-1462 NN denotes PC
T10802 1463-1466 IN denotes via
T10803 1467-1476 JJ denotes vasogenic
T10804 1477-1482 NN denotes edema
T10805 1483-1492 NN denotes formation
T10806 1493-1496 CC denotes and
T10807 1497-1500 RB denotes not
T10808 1501-1504 IN denotes via
T10809 1505-1511 JJ denotes direct
T10810 1512-1526 JJ denotes TNF-α-mediated
T10811 1527-1532 NN denotes MIP-2
T10812 1533-1543 NN denotes expression
T10813 1544-1546 IN denotes in
T10814 1547-1557 NN denotes astrocytes
R8448 T10563 T10564 arg1Of MIP-2,is
R8449 T10567 T10564 arg2Of chemokine,is
R8450 T10567 T10565 arg1Of chemokine,a
R8451 T10567 T10566 arg1Of chemokine,powerful
R8452 T10567 T10568 arg1Of chemokine,that
R8453 T10567 T10569 arg1Of chemokine,contributes
R8454 T10569 T10570 arg1Of contributes,to
R8455 T10571 T10570 arg2Of recruitment,to
R8456 T10571 T10572 arg1Of recruitment,of
R8457 T10573 T10572 arg2Of neutrophils,of
R8458 T10573 T10574 arg1Of neutrophils,[
R8459 T10575 T10574 arg2Of 27,[
R8460 T10576 T10574 arg3Of ],[
R8461 T10577 T10578 arg1Of MIP-2,is
R8462 T10577 T10579 arg1Of MIP-2,undetectable
R8463 T10577 T10581 arg1Of MIP-2,present
R8464 T10577 T10590 arg1Of MIP-2,shows
R8465 T10578 T10589 arg1Of is,and
R8466 T10579 T10580 arg1Of undetectable,or
R8467 T10580 T10578 arg2Of or,is
R8468 T10580 T10582 arg1Of or,at
R8469 T10581 T10580 arg2Of present,or
R8470 T10584 T10582 arg2Of levels,at
R8471 T10584 T10583 arg1Of levels,low
R8472 T10584 T10585 arg1Of levels,under
R8473 T10587 T10585 arg2Of conditions,under
R8474 T10587 T10586 arg1Of conditions,physiological
R8475 T10589 T10588 arg1Of and,","
R8476 T10590 T10589 arg2Of shows,and
R8477 T10590 T10593 arg1Of shows,under
R8478 T10590 T10596 arg1Of shows,via
R8479 T10592 T10590 arg2Of increases,shows
R8480 T10592 T10591 arg1Of increases,transient
R8481 T10595 T10593 arg2Of conditions,under
R8482 T10595 T10594 arg1Of conditions,pathological
R8483 T10597 T10598 arg1Of TNF-α,and/or
R8484 T10598 T10596 arg2Of and/or,via
R8485 T10601 T10600 arg2Of IL-1β,(
R8486 T10602 T10600 arg3Of ),(
R8487 T10604 T10598 arg2Of mechanisms,and/or
R8488 T10604 T10599 arg1Of mechanisms,interleukin-1β
R8489 T10604 T10600 arg1Of mechanisms,(
R8490 T10604 T10603 arg1Of mechanisms,-dependent
R8491 T10604 T10605 arg1Of mechanisms,[
R8492 T10606 T10605 arg2Of 14,[
R8493 T10607 T10605 arg3Of ],[
R8494 T10612 T10608 arg1Of be,Thus
R8495 T10612 T10609 arg1Of be,","
R8496 T10612 T10611 arg2Of be,would
R8497 T10613 T10612 arg2Of plausible,be
R8498 T10617 T10615 arg1Of expression,TNF-α-mediated
R8499 T10617 T10616 arg1Of expression,MIP-2
R8500 T10617 T10618 arg1Of expression,may
R8501 T10617 T10619 arg1Of expression,provoke
R8502 T10619 T10610 arg1Of provoke,it
R8503 T10619 T10611 arg1Of provoke,would
R8504 T10619 T10612 arg1Of provoke,be
R8505 T10619 T10613 arg1Of provoke,plausible
R8506 T10619 T10614 arg1Of provoke,that
R8507 T10619 T10618 arg2Of provoke,may
R8508 T10622 T10619 arg2Of infiltrations,provoke
R8509 T10622 T10620 arg1Of infiltrations,SE-induced
R8510 T10622 T10621 arg1Of infiltrations,neutrophil
R8511 T10624 T10623 arg1Of confirm,To
R8512 T10626 T10624 arg2Of hypothesis,confirm
R8513 T10626 T10625 arg1Of hypothesis,this
R8514 T10628 T10624 arg1Of we,confirm
R8515 T10628 T10629 arg1Of we,investigated
R8516 T10629 T10623 modOf investigated,To
R8517 T10629 T10627 arg1Of investigated,","
R8518 T10631 T10629 arg2Of expression,investigated
R8519 T10631 T10630 arg1Of expression,MIP-2
R8520 T10631 T10632 arg1Of expression,in
R8521 T10634 T10632 arg2Of PC,in
R8522 T10634 T10633 arg1Of PC,the
R8523 T10635 T10636 arg1Of Consistent,with
R8524 T10639 T10636 arg2Of study,with
R8525 T10639 T10637 arg1Of study,our
R8526 T10639 T10638 arg1Of study,previous
R8527 T10639 T10640 arg1Of study,[
R8528 T10641 T10640 arg2Of 20,[
R8529 T10642 T10640 arg3Of ],[
R8530 T10646 T10635 arg1Of astrocytes,Consistent
R8531 T10646 T10644 arg1Of astrocytes,some
R8532 T10646 T10645 arg1Of astrocytes,MIP-2-positive
R8533 T10646 T10647 arg1Of astrocytes,were
R8534 T10646 T10648 arg2Of astrocytes,observed
R8535 T10648 T10635 modOf observed,Consistent
R8536 T10648 T10643 arg1Of observed,","
R8537 T10648 T10647 arg2Of observed,were
R8538 T10648 T10649 arg1Of observed,in
R8539 T10648 T10662 arg1Of observed,in
R8540 T10649 T10660 arg1Of in,but
R8541 T10651 T10652 arg1Of core,and
R8542 T10652 T10649 arg2Of and,in
R8543 T10652 T10650 arg1Of and,the
R8544 T10652 T10654 arg1Of and,of
R8545 T10653 T10652 arg2Of periphery,and
R8546 T10658 T10654 arg2Of lesions,of
R8547 T10658 T10655 arg1Of lesions,the
R8548 T10658 T10656 arg1Of lesions,vasogenic
R8549 T10658 T10657 arg1Of lesions,edema
R8550 T10660 T10659 arg1Of but,","
R8551 T10662 T10660 arg2Of in,but
R8552 T10662 T10661 arg1Of in,not
R8553 T10666 T10662 arg2Of region,in
R8554 T10666 T10663 arg1Of region,the
R8555 T10666 T10664 arg1Of region,non-vasogenic
R8556 T10666 T10665 arg1Of region,edema
R8557 T10666 T10667 arg1Of region,(
R8558 T10669 T10668 arg1Of 6B,Figure
R8559 T10669 T10670 arg1Of 6B,and
R8560 T10670 T10667 arg2Of and,(
R8561 T10671 T10670 arg2Of 6C,and
R8562 T10672 T10667 arg3Of ),(
R8563 T10675 T10674 arg1Of number,the
R8564 T10675 T10676 arg1Of number,of
R8565 T10675 T10690 arg1Of number,was
R8566 T10675 T10692 arg1Of number,lower
R8567 T10679 T10676 arg2Of cells,of
R8568 T10679 T10677 arg1Of cells,MIP-2
R8569 T10679 T10678 arg1Of cells,positive
R8570 T10679 T10680 arg1Of cells,per
R8571 T10682 T10680 arg2Of area,per
R8572 T10682 T10681 arg1Of area,unit
R8573 T10682 T10683 arg1Of area,in
R8574 T10686 T10683 arg2Of region,in
R8575 T10686 T10684 arg1Of region,the
R8576 T10686 T10685 arg1Of region,PC
R8577 T10686 T10687 arg1Of region,of
R8578 T10689 T10687 arg2Of animals,of
R8579 T10689 T10688 arg1Of animals,sTNFp55R-infused
R8580 T10690 T10673 arg2Of was,Although
R8581 T10692 T10690 arg2Of lower,was
R8582 T10692 T10691 arg1Of lower,significantly
R8583 T10692 T10693 arg1Of lower,than
R8584 T10692 T10700 arg1Of lower,to
R8585 T10694 T10693 arg2Of that,than
R8586 T10694 T10695 arg1Of that,of
R8587 T10698 T10695 arg2Of group,of
R8588 T10698 T10696 arg1Of group,the
R8589 T10698 T10697 arg1Of group,saline-infused
R8590 T10698 T10699 arg1Of group,due
R8591 T10701 T10700 arg2Of reduction,to
R8592 T10701 T10702 arg1Of reduction,of
R8593 T10704 T10702 arg2Of area,of
R8594 T10704 T10703 arg1Of area,the
R8595 T10704 T10705 arg1Of area,of
R8596 T10707 T10705 arg2Of edema,of
R8597 T10707 T10706 arg1Of edema,vasogenic
R8598 T10709 T10710 arg1Of there,was
R8599 T10710 T10673 arg1Of was,Although
R8600 T10710 T10708 arg1Of was,","
R8601 T10712 T10710 arg2Of difference,was
R8602 T10712 T10711 arg1Of difference,no
R8603 T10712 T10713 arg1Of difference,in
R8604 T10712 T10720 arg1Of difference,per
R8605 T10715 T10713 arg2Of number,in
R8606 T10715 T10714 arg1Of number,the
R8607 T10715 T10716 arg1Of number,of
R8608 T10719 T10716 arg2Of cells,of
R8609 T10719 T10717 arg1Of cells,MIP-2
R8610 T10719 T10718 arg1Of cells,positive
R8611 T10722 T10720 arg2Of area,per
R8612 T10722 T10721 arg1Of area,unit
R8613 T10722 T10723 arg1Of area,of
R8614 T10725 T10723 arg2Of edema,of
R8615 T10725 T10724 arg1Of edema,vasogenic
R8616 T10725 T10726 arg1Of edema,between
R8617 T10728 T10727 arg1Of animals,sTNFp55R-infused
R8618 T10728 T10729 arg1Of animals,and
R8619 T10729 T10726 arg2Of and,between
R8620 T10731 T10729 arg2Of animals,and
R8621 T10731 T10730 arg1Of animals,saline-infused
R8622 T10731 T10732 arg1Of animals,(
R8623 T10734 T10732 arg2Of 6F,(
R8624 T10734 T10733 arg1Of 6F,Figure
R8625 T10735 T10732 arg3Of ),(
R8626 T10739 T10738 arg1Of number,the
R8627 T10739 T10740 arg1Of number,of
R8628 T10739 T10743 arg1Of number,showed
R8629 T10742 T10740 arg2Of cells,of
R8630 T10742 T10741 arg1Of cells,MIP-2-positive
R8631 T10743 T10736 arg1Of showed,Furthermore
R8632 T10743 T10737 arg1Of showed,","
R8633 T10746 T10743 arg2Of proportion,showed
R8634 T10746 T10744 arg1Of proportion,a
R8635 T10746 T10745 arg1Of proportion,direct
R8636 T10746 T10747 arg1Of proportion,to
R8637 T10750 T10747 arg2Of area,to
R8638 T10750 T10748 arg1Of area,the
R8639 T10750 T10749 arg1Of area,unit
R8640 T10750 T10751 arg1Of area,of
R8641 T10750 T10754 arg1Of area,with
R8642 T10753 T10751 arg2Of edema,of
R8643 T10753 T10752 arg1Of edema,vasogenic
R8644 T10757 T10754 arg2Of coefficient,with
R8645 T10757 T10755 arg1Of coefficient,a
R8646 T10757 T10756 arg1Of coefficient,linear
R8647 T10757 T10758 arg1Of coefficient,of
R8648 T10759 T10758 arg2Of correlation,of
R8649 T10759 T10760 arg1Of correlation,of
R8650 T10761 T10760 arg2Of 0.682,of
R8651 T10761 T10762 arg1Of 0.682,(
R8652 T10763 T10762 arg2Of p,(
R8653 T10763 T10764 arg1Of p,<
R8654 T10763 T10765 arg1Of p,0.05
R8655 T10763 T10766 arg1Of p,","
R8656 T10768 T10766 arg2Of 6G,","
R8657 T10768 T10767 arg1Of 6G,Figure
R8658 T10769 T10762 arg3Of ),(
R8659 T10773 T10772 arg1Of with,together
R8660 T10774 T10773 arg2Of reduction,with
R8661 T10774 T10775 arg1Of reduction,in
R8662 T10777 T10775 arg2Of infiltration,in
R8663 T10777 T10776 arg1Of infiltration,neutrophil
R8664 T10777 T10778 arg1Of infiltration,in
R8665 T10781 T10778 arg2Of region,in
R8666 T10781 T10779 arg1Of region,the
R8667 T10781 T10780 arg1Of region,PC
R8668 T10781 T10782 arg1Of region,of
R8669 T10784 T10782 arg2Of animals,of
R8670 T10784 T10783 arg1Of animals,sTNFp55R-infused
R8671 T10787 T10786 arg1Of findings,our
R8672 T10787 T10788 arg1Of findings,provide
R8673 T10788 T10770 arg1Of provide,Therefore
R8674 T10788 T10771 arg1Of provide,","
R8675 T10788 T10773 arg1Of provide,with
R8676 T10788 T10785 arg1Of provide,","
R8677 T10789 T10788 arg2Of evidence,provide
R8678 T10791 T10792 arg1Of TNF-α,may
R8679 T10791 T10793 arg1Of TNF-α,regulate
R8680 T10793 T10789 arg2Of regulate,evidence
R8681 T10793 T10790 arg1Of regulate,that
R8682 T10793 T10792 arg2Of regulate,may
R8683 T10793 T10799 arg1Of regulate,in
R8684 T10793 T10808 arg1Of regulate,via
R8685 T10796 T10793 arg2Of infiltration,regulate
R8686 T10796 T10794 arg1Of infiltration,SE-induced
R8687 T10796 T10795 arg1Of infiltration,neutrophil
R8688 T10798 T10797 arg1Of least,at
R8689 T10799 T10798 arg1Of in,least
R8690 T10799 T10806 arg1Of in,and
R8691 T10801 T10799 arg2Of PC,in
R8692 T10801 T10800 arg1Of PC,the
R8693 T10801 T10802 arg1Of PC,via
R8694 T10805 T10802 arg2Of formation,via
R8695 T10805 T10803 arg1Of formation,vasogenic
R8696 T10805 T10804 arg1Of formation,edema
R8697 T10808 T10806 arg2Of via,and
R8698 T10808 T10807 arg1Of via,not
R8699 T10812 T10808 arg2Of expression,via
R8700 T10812 T10809 arg1Of expression,direct
R8701 T10812 T10810 arg1Of expression,TNF-α-mediated
R8702 T10812 T10811 arg1Of expression,MIP-2
R8703 T10812 T10813 arg1Of expression,in
R8704 T10814 T10813 arg2Of astrocytes,in